Ensign Peak Advisors
ADPT icon

Ensign Peak Advisors’s Adaptive Biotechnologies ADPT Stock Holding History

Ensign Peak Advisors’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Sell
120,770
-70
-0.1% -$1.07K ﹤0.01% 686
2026
Q1 		$1.68M Sell
120,840
-19,327
-14% -$308K ﹤0.01% 742
2025
Q4 		$2.28M Sell
140,167
-9,810
-7% -$160K ﹤0.01% 680
2025
Q3 		$2.24M Buy
+149,977
New +$1.83M ﹤0.01% 775
2022
Q4 		– Sell
-14,700
Closed -$105K – 1791
2022
Q3 		$105K Hold
14,700
– – ﹤0.01% 2081
2022
Q2 		$119K Sell
14,700
-14,562
-50% -$128K ﹤0.01% 1928
2022
Q1 		$406K Sell
29,262
-43,832
-60% -$689K ﹤0.01% 1640
2021
Q4 		$2.05M Sell
73,094
-9,970
-12% -$306K ﹤0.01% 942
2021
Q3 		$2.82M Buy
83,064
+6,032
+8% +$218K 0.01% 917
2021
Q2 		$3.15M Sell
77,032
-5,711
-7% -$222K 0.01% 858
2021
Q1 		$3.33M Sell
82,743
-12,385
-13% -$670K 0.01% 814
2020
Q4 		$5.63M Sell
95,128
-18,303
-16% -$944K 0.01% 570
2020
Q3 		$5.51M Buy
113,431
+52,549
+86% +$2.21M 0.01% 599
2020
Q2 		$2.94M Sell
60,882
-7,599
-11% -$277K 0.01% 781
2020
Q1 		$1.9M Buy
68,481
+60,033
+711% +$1.67M 0.01% 855
2019
Q4 		$252K Buy
+8,448
New +$243K ﹤0.01% 1609

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ensign Peak Advisors's ADPT Position: Q2 2026 in Review

Ensign Peak Advisors reduced its Adaptive Biotechnologies (ADPT) stake by 0.06% in Q2 2026, selling an estimated $1.07K and leaving 120,770 shares worth $2.59M. The position accounts for ﹤0.01% of the portfolio, ranked #686.

Ensign Peak Advisors first reported a position in ADPT in Q4 2019 and has held it in 16 quarters since. The position peaked at $5.63M in Q4 2020. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Ensign Peak Advisors held 120,770 shares of Adaptive Biotechnologies worth $2.59M as of Q2 2026.
  • Ensign Peak Advisors sold 70 Adaptive Biotechnologies shares in Q2 2026, an estimated $1.07K.
  • Adaptive Biotechnologies made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q2 2026, its #686 holding.
  • Ensign Peak Advisors first reported a position in Adaptive Biotechnologies in Q4 2019 and has held it in 16 quarters since.
  • Ensign Peak Advisors's Adaptive Biotechnologies position peaked at $5.63M in Q4 2020.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.